University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Michael R. Harrison, M.D.

Fetal and pediatric surgeon

Dr. Michael Harrison is director emeritus and co-founder of the Fetal Treatment Center at UCSF Benioff Children's Hospital. He is an internationally known expert in fetal surgery, an area he helped pioneer with his colleagues at UCSF. For more than 25 years, he has studied how life-threatening fetal abnormalities alter normal physical processes. He developed techniques for both open surgery and minimally invasive surgery to repair many birth defects. Harrison's team also developed in utero stem cell transplantation to treat immune system deficiencies, enzyme deficiencies and abnormal hemoglobin in the blood.

Harrison graduated cum laude from Yale University and magna cum laude from Harvard Medical School. He completed surgical training at Massachusetts General Hospital in Boston and a pediatric surgery fellowship at Children's Hospital of Los Angeles. He is a professor emeritus of surgery, pediatrics, obstetrics, gynecology and reproductive sciences.

Clinics

Fetal Treatment Center
1855 Fourth St., Second Floor
San Francisco, CA 94158
Phone: (800) 793-3887
Fax: (415) 502-0660

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about Michael R. Harrison

Additional Languages

Spanish

Education

Harvard University School of Medicine 1969

Residencies

Massachusetts General Hospital, General Surgery 1975

Fellowships

Los Angeles Children's Hospital, Pediatric Surgery 1978

Selected Research and Publications

  1. Davis K, Wood S, Dill E, Yuri Fesko YF, Bitting RL, Harrison MR, Armstrong AJ, Moul JW, George DJ. Optimizing the efficiency and quality of sipuleucel-T delivery in an academic institution. Clin J Oncol Nurs. 2015 Jun 1; 19(3):297-303.
  2. Harrison MR, Bussmann J, Huang Y, Zhao L, Osorio A, Burns CG, Burns CE, Sucov HM, Siekmann AF, Lien CL. Chemokine-guided angiogenesis directs coronary vasculature formation in zebrafish. Dev Cell. 2015 May 26; 33(4):442-54.
  3. Swisher SL, Lin MC, Liao A, Leeflang EJ, Khan Y, Pavinatto FJ, Mann K, Naujokas A, Young D, Roy S, Harrison MR, Arias AC, Subramanian V, Maharbiz MM. Impedance sensing device enables early detection of pressure ulcers in vivo. Nat Commun. 2015; 6:6575.
  4. Stover JT, Moore RA, Davis K, Harrison MR, Armstrong AJ. Reversal of PSA progression on abiraterone acetate through the administration with food in men with metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2015 Jun; 18(2):161-6.
  5. Iqbal CW, Wall J, Harrison MR. Challenges and climate of business environment and resources to support pediatric device development. Semin Pediatr Surg. 2015 Jun; 24(3):107-11.
  6. Harrison MR, Emamaullee JE, Besner GE. Profiles in surgical research: Michael R. Harrison, MD, FACS. Bull Am Coll Surg. 2015 Jan; 100(1):35-40.
  7. Mitchell AP, Hirsch BR, Harrison MR, Abernethy AP, George DJ. Deferred systemic therapy in patients with metastatic renal cell carcinoma. Clin Genitourin Cancer. 2015 Jun; 13(3):e159-66.
  8. Motzer RJ, Rini BI, McDermott DF, Redman BG, Kuzel TM, Harrison MR, Vaishampayan UN, Drabkin HA, George S, Logan TF, Margolin KA, Plimack ER, Lambert AM, Waxman IM, Hammers HJ. Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial. J Clin Oncol. 2015 May 1; 33(13):1430-7.
  9. Li R, Beebe T, Jen N, Yu F, Takabe W, Harrison M, Cao H, Lee J, Yang H, Han P, Wang K, Shimizu H, Chen J, Lien CL, Chi NC, Hsiai TK. Shear stress-activated Wnt-angiopoietin-2 signaling recapitulates vascular repair in zebrafish embryos. Arterioscler Thromb Vasc Biol. 2014 Oct; 34(10):2268-75.
  10. Hirsch BR, Harrison MR, George DJ, Walker MS, Chen C, Korytowsky B, Stepanski E, Abernethy AP. Use of "Real-World" data to describe adverse events during the treatment of metastatic renal cell carcinoma in routine clinical practice. Med Oncol. 2014 Sep; 31(9):156.
  11. Miniaturizing RFID for magnamosis. Conf Proc IEEE Eng Med Biol Soc. 2014 Aug; 2014:638-41.
  12. Hirsch BR, George DJ, Harrison MR. Treatment selection in metastatic renal cell carcinoma: more confusion or a path forward? Clin Adv Hematol Oncol. 2014 Mar; 12(3):163-71.
  13. Gamba L, Harrison M, Lien CL. Cardiac regeneration in model organisms. Curr Treat Options Cardiovasc Med. 2014 Mar; 16(3):288.
  14. Harrison MR, Armstrong AJ. Burden of disease matters when it comes to systemic therapy for prostate cancer. Eur Urol. 2015 Mar; 67(3):448-50.
  15. Harrison MR, Jones LW. Exercise as treatment for androgen deprivation therapy-associated physical dysfunction: ready for prime time? Eur Urol. 2014 May; 65(5):873-4.
  16. Harrison MR, Hirsch BR, George DJ, Walker MS, Chen C, Korytowsky B, Stepanski E, Abernethy AP. Real-world outcomes in metastatic renal cell carcinoma: insights from a Joint Community-Academic Registry. J Oncol Pract. 2014 Mar; 10(2):e63-72.
  17. McLaughlin M, Kotis D, Thomson K, Harrison M, Fennessy G, Postelnick M, Scheetz M. Empty shelves, full of frustration: consequences of drug shortages and the need for action. Hosp Pharm. 2013 Sep; 48(8):617-8.
  18. Jiang H, Zhang J, Lan D. A low-frequency versatile wireless power transfer technology for biomedical implants. IEEE Trans Biomed Circuits Syst. 2013 Aug; 7(4):526-35.
  19. Harrison MR, George DJ, Walker MS, Chen C, Korytowsky B, Kirkendall DT, Stepanski EJ, Abernethy AP. "Real world" treatment of metastatic renal cell carcinoma in a joint community-academic cohort: progression-free survival over three lines of therapy. Clin Genitourin Cancer. 2013 Dec; 11(4):441-50.
  20. Plantmason LR, Xu G, Harrison MR, Maa J. Novel use of a magnet to help remove metallic foreign bodies from the gastrointestinal tract. Am Surg. 2012 Nov; 78(11):E472-3.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.